231 related articles for article (PubMed ID: 28106099)
21. Synphilin-1 has neuroprotective effects on MPP
Shishido T; Nagano Y; Araki M; Kurashige T; Obayashi H; Nakamura T; Takahashi T; Matsumoto M; Maruyama H
Neurosci Lett; 2019 Jan; 690():145-150. PubMed ID: 30316984
[TBL] [Abstract][Full Text] [Related]
22. Guanosine exerts neuroprotective effects by reversing mitochondrial dysfunction in a cellular model of Parkinson's disease.
Li DW; Yao M; Dong YH; Tang MN; Chen W; Li GR; Sun BQ
Int J Mol Med; 2014 Nov; 34(5):1358-64. PubMed ID: 25174304
[TBL] [Abstract][Full Text] [Related]
23. Paeonolum protects against MPP(+)-induced neurotoxicity in zebrafish and PC12 cells.
Lu XL; Lin YH; Wu Q; Su FJ; Ye CH; Shi L; He BX; Huang FW; Pei Z; Yao XL
BMC Complement Altern Med; 2015 Apr; 15():137. PubMed ID: 25925762
[TBL] [Abstract][Full Text] [Related]
24. Pinostrobin Exerts Neuroprotective Actions in Neurotoxin-Induced Parkinson's Disease Models through Nrf2 Induction.
Li C; Tang B; Feng Y; Tang F; Pui-Man Hoi M; Su Z; Ming-Yuen Lee S
J Agric Food Chem; 2018 Aug; 66(31):8307-8318. PubMed ID: 29961319
[TBL] [Abstract][Full Text] [Related]
25. Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization.
Lee Y; Park HR; Chun HJ; Lee J
J Neurosci Res; 2015 May; 93(5):755-65. PubMed ID: 25677261
[TBL] [Abstract][Full Text] [Related]
26. Phytic acid attenuates inflammatory responses and the levels of NF-κB and p-ERK in MPTP-induced Parkinson's disease model of mice.
Lv Y; Zhang Z; Hou L; Zhang L; Zhang J; Wang Y; Liu C; Xu P; Liu L; Gai X; Lu T
Neurosci Lett; 2015 Jun; 597():132-6. PubMed ID: 25929185
[TBL] [Abstract][Full Text] [Related]
27. Targeted deletion of the aquaglyceroporin AQP9 is protective in a mouse model of Parkinson's disease.
Stahl K; Rahmani S; Prydz A; Skauli N; MacAulay N; Mylonakou MN; Torp R; Skare Ø; Berg T; Leergaard TB; Paulsen RE; Ottersen OP; Amiry-Moghaddam M
PLoS One; 2018; 13(3):e0194896. PubMed ID: 29566083
[TBL] [Abstract][Full Text] [Related]
28. PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease.
Choi YJ; Kim DW; Shin MJ; Yeo HJ; Yeo EJ; Lee LR; Song Y; Kim DS; Han KH; Park J; Lee KW; Park JK; Eum WS; Choi SY
Molecules; 2021 Jun; 26(11):. PubMed ID: 34206041
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of MPTP/MPP(+) toxicity in vivo and in vitro by an 18-mer peptide derived from prosaposin.
Gao HL; Li C; Nabeka H; Shimokawa T; Saito S; Wang ZY; Cao YM; Matsuda S
Neuroscience; 2013 Apr; 236():373-93. PubMed ID: 23321539
[TBL] [Abstract][Full Text] [Related]
30. The Neuroprotective Role of Insulin Against MPP(+) -Induced Parkinson's Disease in Differentiated SH-SY5Y Cells.
Ramalingam M; Kim SJ
J Cell Biochem; 2016 Apr; 117(4):917-26. PubMed ID: 26364587
[TBL] [Abstract][Full Text] [Related]
31. Involvement of IGF-1 receptor signaling pathway in the neuroprotective effects of Icaritin against MPP(+)-induced toxicity in MES23.5 cells.
Jiang MC; Chen XH; Zhao X; Zhang XJ; Chen WF
Eur J Pharmacol; 2016 Sep; 786():53-59. PubMed ID: 27238975
[TBL] [Abstract][Full Text] [Related]
32. Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling.
Weng Z; Signore AP; Gao Y; Wang S; Zhang F; Hastings T; Yin XM; Chen J
J Biol Chem; 2007 Nov; 282(47):34479-91. PubMed ID: 17895242
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective effects of an herbal medicine, Yi-Gan San on MPP+/MPTP-induced cytotoxicity in vitro and in vivo.
Doo AR; Kim SN; Park JY; Cho KH; Hong J; Eun-Kyung K; Moon SK; Jung WS; Lee H; Jung JH; Park HJ
J Ethnopharmacol; 2010 Sep; 131(2):433-42. PubMed ID: 20633628
[TBL] [Abstract][Full Text] [Related]
34. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
[TBL] [Abstract][Full Text] [Related]
35. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T
Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118
[TBL] [Abstract][Full Text] [Related]
36. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-d-glucoside attenuates MPP+/MPTP-induced neurotoxicity in vitro and in vivo by restoring the BDNF-TrkB and FGF2-Akt signaling axis and inhibition of apoptosis.
Yu Y; Lang XY; Li XX; Gu RZ; Liu QS; Lan R; Qin XY
Food Funct; 2019 Sep; 10(9):6009-6019. PubMed ID: 31482900
[TBL] [Abstract][Full Text] [Related]
37. Small peptide inhibitor of JNKs protects against MPTP-induced nigral dopaminergic injury via inhibiting the JNK-signaling pathway.
Pan J; Qian J; Zhang Y; Ma J; Wang G; Xiao Q; Chen S; Ding J
Lab Invest; 2010 Feb; 90(2):156-67. PubMed ID: 20010851
[TBL] [Abstract][Full Text] [Related]
38. Methylene blue protects dopaminergic neurons against MPTP-induced neurotoxicity by upregulating brain-derived neurotrophic factor.
Bhurtel S; Katila N; Neupane S; Srivastav S; Park PH; Choi DY
Ann N Y Acad Sci; 2018 Nov; 1431(1):58-71. PubMed ID: 29882218
[TBL] [Abstract][Full Text] [Related]
39. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
[TBL] [Abstract][Full Text] [Related]
40. α-lipoic acid protects dopaminergic neurons against MPP+-induced apoptosis by attenuating reactive oxygen species formation.
Li DW; Li GR; Lu Y; Liu ZQ; Chang M; Yao M; Cheng W; Hu LS
Int J Mol Med; 2013 Jul; 32(1):108-14. PubMed ID: 23615851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
